| memantine / Generic mfg. |
| Unknown status | N/A | 180 | Europe | Memantine Hydrochloride | King's College London | Down's Syndrome, Dementia, Learning Disabilities | | | | |
| Completed | N/A | 12 | Europe | memantine (drug) | University of Aarhus, Lundbeck Foundation | Parkinson's Disease | | 09/06 | | |
NCT00988663: The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems? |
|
|
| Withdrawn | N/A | 0 | US | memantine, Namenda, Placebo | Jerrry L Lewis | Major Depressive Disorder | 11/09 | 11/09 | | |
NCT01038128: An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder |
|
|
| Completed | N/A | 5 | US | Memantine, Namenda | Mclean Hospital | Bulimia Nervosa, Body Dysmorphic Disorder | 05/11 | 05/11 | | |
NCT00954616: Inappropriate Medications Associated With Anticholinesterase and/or Memantine Treatment in the Elderly |
|
|
| Completed | N/A | 636 | Europe | | University Hospital, Limoges | Alzheimer's Disease | 07/11 | 01/12 | | |
NCT01533493: Memantine for Executive Dysfunction in Adults With ADHD: A Pilot Study |
|
|
| Completed | N/A | 33 | US | Placebo, Memantine Hydrochloride, Namenda, OROS-Methylphenidate, OROS-MPH, Concerta | Massachusetts General Hospital, The American Professional Society of ADHD and Related Disorders (APSARD) | Attention Deficit Hyperactivity Disorder (ADHD), Executive Function Deficits (EFD) | 07/13 | 08/13 | | |
NCT00703430: Memantine on Aggression and Agitation of Alzheimer's Disease (AD) |
|
|
| Unknown status | N/A | 50 | RoW | Memantine, Ebixa® | Peking University, H. Lundbeck A/S | Alzheimer's Disease | 12/13 | 06/14 | | |
NCT01844427: Memantine Monotherapy for Executive Dysfunction and ADHD |
|
|
| Withdrawn | N/A | 0 | US | Memantine, Namenda, Placebo | Massachusetts General Hospital | ADHD, Executive Function Deficits (EFD's) | 03/15 | | | |
NCT02136823: Impact of Persistent Conductances on Motor Unit Firing in SCI |
|
|
| Unknown status | N/A | 50 | NA | sugar pill, placebo, Riluzole, Rilutek, Isradipine, Memantine, Namenda, Therapeutic muscle stretching | Shirley Ryan AbilityLab | Chronic Spinal Cord Injury | 05/15 | | | |
NCT02162251: Post-marketing Surveillance of Donepezil Hydrochloride Investigation of the Safety and Effectiveness of Combination Therapy of Donepezil Hydrochloride and Memantine Hydrochloride in Patients With Alzheimer's Disease |
|
|
| Completed | N/A | 3482 | Japan | Donepezil Hydrochloride, Aricept | Eisai Co., Ltd. | Alzheimer's Desease | 05/15 | 04/16 | | |
NCT02240589: Memantine for Neuroprotection and Cognitive Enhancement Following Traumatic Brain Injury |
|
|
| Completed | N/A | 11 | US | Memantine, Namenda, Placebo | Indiana University | Traumatic Brain Injury | 04/16 | 04/16 | | |
NCT02233556: Effect of Memantine on ERP in Early Schizophrenia and Healthy Subjects |
|
|
| Unknown status | N/A | 20 | RoW | Memantine, Ebixa 10 mg, manufactured by Lunbeck A/S, Denmark | National Taiwan University Hospital | Schizophrenia | 12/16 | 12/16 | | |
NCT05102045: The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease |
|
|
| Completed | N/A | 27 | RoW | Repetitive Transcranial Magnetic Stimulation, Aerobic Exercise, Acetylcholinesterase Inhibitors, Memantine | Istanbul Medipol University Hospital | Alzheimer Disease | 05/17 | 06/17 | | |
ChiCTR-IPR-16008425: Efficacy of quetiapine in behavioral and psychological symptoms of Alzheimer's disease patients |
|
|
| Not yet recruiting | N/A | 120 | | Quetiapine ;Memantine | Changning Mental Health Center; Changning Mental Health Center, Key program of the Changning Science and Technology Committee | Alzheimer's disease | | | | |
| Completed | N/A | 50 | Europe | Memantine, Dopamine receptor-agonists, Memantine: Ebixa. Dopamine receptor-agonists: Sinemet, Sirio. | University of Pisa | Neuro-Degenerative Disease | 12/18 | 03/19 | | |
| Unknown status | N/A | 30 | RoW | Deep brain stimulation, Deep brain stimulation electrodes (Medtronic or Abbott), Best medical treatment for Alzheimer's disease, Exelon (Rivastigmine Tartrate), Witgen (Memantine) | Buddhist Tzu Chi General Hospital, Beijing Tiantan Hospital | Alzheimer Disease, Dementia, Alzheimer Type, Deep Brain Stimulation | 09/20 | 09/21 | | |
NCT05531383: Effect of Early Memantine Administration on Outcome of Patients With Moderate to Severe Traumatic Brain Injury |
|
|
| Active, not recruiting | N/A | 70 | RoW | Memantine Hydrochloride, Namenda | Minia University | Traumatic Brain Injury | 11/23 | 07/24 | | |
| Recruiting | N/A | 60 | RoW | AChE inhibitor monotherapy, Donepezil, AChE inhibitor and NMDA receptor antagonist combination therapy, Donepezil and Memantine combination therapy | University of the Philippines | Alzheimer Disease | 12/23 | 02/25 | | |
FOCI, ChiCTR2200062493: A real-world study of factors related to disease outcome in patients with various types of subjective cognitive impairment, mild cognitive impairment, and dementia |
|
|
| Not yet recruiting | N/A | 500 | | Donepezil ;Memantine ;Sodium oligomannate ;Other medicine | The First Affiliated Hospital of Kunming Medical University; The First Affiliated Hospital of Kunming Medical University, Science and Technology Innovation Team Construction Project of Kunming Medical University (Project No. CXTD202104) | Subjective cognitive impairment, mild cognitive impairment, and dementia | | | | |
